Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):443-448. doi: 10.1182/hematology.2019000051.
Recent advances in genomics have greatly expanded the spectrum of primary immune deficiencies (PIDs). Along with the identification of pathogenic variants in novel genes, distinct phenotypes have been associated with different variants in the same gene. Although PIDs have been historically defined based on increased susceptibility to infections, immune dysregulation has emerged as a frequent and in some cases, predominant phenotype. Autoimmune cytopenias with onset in childhood, lasting longer than 12 months, and affecting multiple lineages should raise the suspicion of a possible PID with monogenic origin. Characterization of the various molecular and cellular mechanisms responsible for these unusual manifestations of PIDs, although at times resource intensive, may allow for targeted intervention in many of them.
基因组学的最新进展极大地扩展了原发性免疫缺陷(PID)的范围。随着对新基因中致病变异的鉴定,同一基因中的不同变异与不同的表型相关。尽管 PID 历史上是基于对感染的易感性增加来定义的,但免疫失调已成为一种常见的表型,在某些情况下甚至是主要表型。儿童期发病、持续时间超过 12 个月且影响多个谱系的自身免疫性血细胞减少症应引起对可能具有单基因起源的 PID 的怀疑。尽管有时资源密集,但对这些 PID 异常表现负责的各种分子和细胞机制进行表征,可能会对其中许多机制进行靶向干预。